+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Somatostatin"

From
From
From
From
Radioligand Therapeutics in Cancer Treatment: Global Markets - Product Thumbnail Image

Radioligand Therapeutics in Cancer Treatment: Global Markets

  • Report
  • February 2026
  • 106 Pages
  • Global
From
From
Pituitary Cancer Market in the United States - Product Thumbnail Image

Pituitary Cancer Market in the United States

  • Report
  • May 2026
  • 210 Pages
  • United States
From
Neuroendocrine Tumor Treatment Market in United States - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market in United States

  • Report
  • February 2026
  • 150 Pages
  • United States
From
From
Loading Indicator

Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer. Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production. Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less Read more